Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Miller, CR; Chappell, NP; Leath, CA; Phippen, NT; Havrilesky, LJ; Barnett, JC

Published Date

  • April 2015

Published In

Volume / Issue

  • 137 /

Start / End Page

  • 170 - 170

Published By

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2015.01.427